J L Ferrero

3.8k total citations
11 papers, 434 citations indexed

About

J L Ferrero is a scholar working on Pharmacology, Pharmacology and Organic Chemistry. According to data from OpenAlex, J L Ferrero has authored 11 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 3 papers in Pharmacology and 2 papers in Organic Chemistry. Recurrent topics in J L Ferrero's work include Pharmacogenetics and Drug Metabolism (7 papers), Analytical Chemistry and Chromatography (2 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). J L Ferrero is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Analytical Chemistry and Chromatography (2 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). J L Ferrero collaborates with scholars based in United States and United Kingdom. J L Ferrero's co-authors include A. David Rodrigues, John O’Gorman, Jeff Sevigny, Alvydas Mikulskis, Leslie Williams, Manjunath S. Shet, Joseph M. Machinist, Michael Kukulka, Barbara A. Bopp and Keith G. Tolman and has published in prestigious journals such as Life Sciences, Drug Metabolism and Disposition and Advances in pharmacology.

In The Last Decade

J L Ferrero

11 papers receiving 412 citations

Peers

Countries citing papers authored by J L Ferrero

Since Specialization

Citations

This map shows the geographic impact of J L Ferrero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J L Ferrero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J L Ferrero more than expected).

Fields of papers citing papers by J L Ferrero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J L Ferrero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J L Ferrero. The network helps show where J L Ferrero may publish in the future.

Co-authorship network of co-authors of J L Ferrero

This figure shows the co-authorship network connecting the top 25 collaborators of J L Ferrero. A scholar is included among the top collaborators of J L Ferrero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J L Ferrero. J L Ferrero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	First‐in‐human, double‐blind, placebo‐controlled, single‐dose escalation study of aducanumab (BIIB037) in mild‐to‐moderate Alzheimer's disease 2016 ·Alzheimer s & Dementia Translational Research & Clinical Interventions ·J L Ferrero, Leslie Williams, (unknown), (unknown), Alvydas Mikulskis, John O’Gorman, Jeff Sevigny	132
2	Preclinical Pharmacokinetics of a HepDirect Prodrug of a Novel Phosphonate-Containing Thyroid Hormone Receptor Agonist 2008 ·Drug Metabolism and Disposition ·James M. Fujitaki, Edward E. Cable, Bruce R. Ito, Baohong Zhang, Jinzhao Hou, Chun Yang, David A. Bullough, J L Ferrero, Paul D. van Poelje, David L. Linemeyer, Mark D. Erion	27
3	Implication of P450-Metabolite Complex Formation in the Nonlinear Pharmacokinetics and Metabolic Fate of (±)-(1′R,3R)-3-Phenyl-1-[(1′,2′,3′,4′-tetrahydro-5′,6′-methylene-dioxy-1′-naphthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200) in Dogs 2002 ·Drug Metabolism and Disposition ·J L Ferrero, (unknown), Kennan C. Marsh, A. David Rodrigues, John T. Uchic, Alex Buko	1
4	Liver Slices as a Model in Drug Metabolism 1997 ·Advances in pharmacology ·J L Ferrero, Klaus Brendel	16
5	In vitro hepatic metabolism of ABT-418 in chimpanzee (Pan troglodytes). A unique pattern of microsomal flavin-containing monooxygenase-dependent stereoselective N'-oxidation. 1995 ·Drug Metabolism and Disposition ·A. David Rodrigues, Michael Kukulka, J L Ferrero, John R. Cashman	16
6	In vitro metabolism of terfenadine by a purified recombinant fusion protein containing cytochrome P4503A4 and NADPH-P450 reductase. Comparison to human liver microsomes and precision-cut liver tissue slices. 1995 ·Drug Metabolism and Disposition ·A. David Rodrigues, Darcy J. Mulford, (unknown), Bruce W. Surber, Michael Kukulka, J L Ferrero, (unknown), Manjunath S. Shet, R.W. Estabrook	58
7	Identification of the human liver cytochrome P450 enzymes involved in the metabolism of zileuton (ABT-077) and its N-dehydroxylated metabolite, Abbott-66193. 1995 ·Drug Metabolism and Disposition ·Joseph M. Machinist, (unknown), Manjunath S. Shet, J L Ferrero, A. David Rodrigues	40
8	The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans. 1994 ·Drug Metabolism and Disposition ·A. David Rodrigues, J L Ferrero, Maria Amann, (unknown), Steven Cepa, Bruce W. Surber, Joseph M. Machinist, (unknown), James P. Sullivan, David S. Garvey	27
9	Metabolism and disposition of clarithromycin in man. 1990 ·Drug Metabolism and Disposition ·J L Ferrero, Barbara A. Bopp, Kennan C. Marsh, (unknown), (unknown), Danielle Anderson, Janet E. Lamm, Keith G. Tolman, Steven W. Sanders, John H. Cavanaugh	97
10	Kinetics and inhibition of carbonic anhydrase-catalyzed hydrolysis of 2-hydroxy-5-nitro-α-toluenesulfonic acid sultone 1983 ·Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology ·Gautam Sanyal, J L Ferrero, Thomas H. Maren	5
11	Metabolism of caffeine by mouse liver microsomes: GSH or cytosol causes a shift in products from 1, 3, 7-trimethylurate to a substituted diaminouracil 1983 ·Life Sciences ·J L Ferrero, Allen H. Neims	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact